GSK, Pfizer merger won’t cause Nurofen maker any pain, ACCC says
Competition & Consumer Protection May 9, 2019 8:24 pm By Amelia Birnie | Sydney

The Australian Competition and Consumer Commission has signed off on pharmaceutical giant GlaxoSmithKline’s proposed acquisition of fellow heavyweight Pfizer, a merger which will put pain medications Panadol, […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.